Nosha Farhadfar is an Oncology physician affiliated with University of Florida Health. OpenAlex indexes 197 publications with 3,073 citations (h-index 31); ClinicalTrials.gov lists 1 registered study matched to this name.
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
4450 Medical Dr Fl 1
San Antonio, TX 782293710
Telephone
210-575-3817Provider last certified this registry record 14 Dec 2023.
Clinical trials
- Beta-glucan and Fatigue in HSCT Survivors
Sponsor: University of Florida
- Investigating Integrative Therapies for Symptom Management in Adults With Acute Leukemia
Sponsor: University of Florida
- UF-BMT-HSCT-001: A Non-Interventional Study Evaluating Diet in HSCT Survivors
Sponsor: University of Florida
Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.
Industry payments
18 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Incyte CorporationProgram year202573 payments$56,527openpaymentsdata.cms.gov ↗
- GENZYME CORPORATIONProgram year20256 payments$10,523openpaymentsdata.cms.gov ↗
- Janssen Biotech, Inc.Program year20254 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Cancer & immunology
100%Kinase inhibitor100%Jakafi100%Part D<11 patients
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- Donor-Derived Malignancy and Transplantation Morbidity: Risks of Patient and Donor Genetics in Allogeneic Hematopoietic Stem Cell Transplantation
Biology of Blood and Marrow Transplantation
2023 - Association of <scp>ABO</scp> mismatch with the outcomes of allogeneic hematopoietic cell transplantation for acute leukemia
American Journal of Hematology
2023
Similar KOLs
Other experts from the same institution or the same specialty.
John Wingard, MD
University of Florida Health
Barry Byrne, MD
University of Florida Health
Gilbert Upchurch, MD
University of Florida Health
Carmen Allegra, MD
University of Florida Health
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”